Pages not connected to items

Jump to navigation Jump to search

This page lists pages with no connected data item (in namespaces that support connected items). The list is sorted by descending page ID, so that newer pages are listed first.

 

Showing below up to 50 results in range #7,601 to #7,650.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. Publication Date (P100)
  2. First Author Name with et al Display String (P99)
  3. Author Name String (P98)
  4. Author (P97)
  5. Series Ordinal (P96)
  6. Developing vaccines against epidemic-prone emerging infectious diseases (DOI: 10.1007/s00103-019-03061-2) (Q7919)
  7. Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies (DOI: 10.3390/v12030254) (Q7918)
  8. Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review (DOI: 10.3390/pathogens9020148) (Q7917)
  9. Sequential Number of Entry in its Bibliography (P95)
  10. Bibliography Entry in a Publication (Q7916)
  11. License Statement (From DOI: 10.3390/pathogens9020148) (Q7915)
  12. License Statement (Q7914)
  13. Full Bibliography (From DOI: 10.3390/pathogens9020148) (Q7913)
  14. Conflicts of Interest (From DOI: 10.3390/pathogens9020148) (Q7912)
  15. Acknowledgments (From DOI: 10.3390/pathogens9020148) (Q7911)
  16. Author Contributions (From DOI: 10.3390/pathogens9020148) (Q7910)
  17. Table 2 - Examples of recombinant antigens and monoclonal antibodies expressed in plants (From DOI: 10.3390/pathogens9020148) (Q7909)
  18. Table 1 - Advantages and disadvantages of different therapeutic protein production platforms (From DOI: 10.3390/pathogens9020148) (Q7908)
  19. Concluding Remarks section from DOI: 10.3390/pathogens9020148 (Q7907)
  20. Perspectives on Biopharmaceuticals Development section from DOI: 10.3390/pathogens9020148 (Q7906)
  21. Transmission and Symptoms section from DOI: 10.3390/pathogens9020148 (Q7905)
  22. Novel Coronavirus 2019-nCoV section from DOI: 10.3390/pathogens9020148 (Q7904)
  23. Introduction section from DOI: 10.3390/pathogens9020148 (Q7903)
  24. Emergence of Novel Coronavirus 2019-nCoV: Need for Rapid Vaccine and Biologics Development (DOI: 10.3390/pathogens9020148) (Q7889)
  25. 9th paragraph(s) in Discussion section (From DOI: 10.3390/v12030254) (Q7888)
  26. 8th paragraph(s) in Discussion section (From DOI: 10.3390/v12030254) (Q7887)
  27. 7th paragraph(s) in Discussion section (From DOI: 10.3390/v12030254) (Q7886)
  28. 6th paragraph(s) in Discussion section (From DOI: 10.3390/v12030254) (Q7885)
  29. 5th paragraph(s) in Discussion section (From DOI: 10.3390/v12030254) (Q7884)
  30. 4th paragraph(s) in Discussion section (From DOI: 10.3390/v12030254) (Q7883)
  31. 3rd paragraph(s) in Discussion section (From DOI: 10.3390/v12030254) (Q7882)
  32. 2nd paragraph(s) in Discussion section (From DOI: 10.3390/v12030254) (Q7881)
  33. 1st paragraph(s) in Discussion section (From DOI: 10.3390/v12030254) (Q7880)
  34. 6th paragraph(s) in Results: Mapping the SARS-CoV-Derived B cell Epitopes that Are Identical in SARS-CoV-2 section (From DOI: 10.3390/v12030254) (Q7879)
  35. 5th paragraph(s) in Results: Mapping the SARS-CoV-Derived B cell Epitopes that Are Identical in SARS-CoV-2 section (From DOI: 10.3390/v12030254) (Q7878)
  36. 4th paragraph(s) in Results: Mapping the SARS-CoV-Derived B cell Epitopes that Are Identical in SARS-CoV-2 section (From DOI: 10.3390/v12030254) (Q7877)
  37. 3rd paragraph(s) in Results: Mapping the SARS-CoV-Derived B cell Epitopes that Are Identical in SARS-CoV-2 section (From DOI: 10.3390/v12030254) (Q7876)
  38. 2nd paragraph(s) in Results: Mapping the SARS-CoV-Derived B cell Epitopes that Are Identical in SARS-CoV-2 section (From DOI: 10.3390/v12030254) (Q7875)
  39. 1st paragraph(s) in Results: Mapping the SARS-CoV-Derived B cell Epitopes that Are Identical in SARS-CoV-2 section (From DOI: 10.3390/v12030254) (Q7874)
  40. 2nd paragraph(s) in Results: Mapping the SARS-CoV-Derived T Cell Epitopes That Are Identical in SARS-CoV-2, and Determining Those with Greatest Estimated Population Coverage section (From DOI: 10.3390/v12030254) (Q7873)
  41. 1st paragraph(s) in Results: Mapping the SARS-CoV-Derived T Cell Epitopes That Are Identical in SARS-CoV-2, and Determining Those with Greatest Estimated Population Coverage section (From DOI: 10.3390/v12030254) (Q7872)
  42. 2nd paragraph(s) in Results: Structural Proteins of SARS-CoV-2 Are Genetically Similar to SARS-CoV, but Not to MERS-CoV section (From DOI: 10.3390/v12030254) (Q7871)
  43. 1st paragraph(s) in Results: Structural Proteins of SARS-CoV-2 Are Genetically Similar to SARS-CoV, but Not to MERS-CoV section (From DOI: 10.3390/v12030254) (Q7870)
  44. 1st paragraph(s) in Materials and Methods: Data and Code Availability section (From DOI: 10.3390/v12030254) (Q7869)
  45. 1st paragraph(s) in Materials and Methods: Constructing the Phylogenetic Tree section (From DOI: 10.3390/v12030254) (Q7868)
  46. 1st paragraph(s) in Materials and Methods: Population-Coverage-Based T Cell Epitope Selection section (From DOI: 10.3390/v12030254) (Q7867)
  47. 1st paragraph(s) in Materials and Methods: Acquisition and Filtering of Epitope Data section (From DOI: 10.3390/v12030254) (Q7866)
  48. 1st paragraph(s) in Materials and Methods: Acquisition and Processing of Sequence Data section (From DOI: 10.3390/v12030254) (Q7865)
  49. 5th paragraph(s) in Introduction (From DOI: 10.3390/v12030254) (Q7864)
  50. 4th paragraph(s) in Introduction (From DOI: 10.3390/v12030254) (Q7863)

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

Retrieved from "http://wikibase.slis.ua.edu/wiki/Special:UnconnectedPages"